Drug intelligence / Profile preview

Soratinex

Development stage
Unknown
Lead developer
Tirsel
Modality
Small Molecules
Administration
Topical
01

Overview

Soratinex (also known as Dr. Michaels) is a topical, steroid-free treatment system developed for the management of chronic plaque psoriasis. The system consists of three distinct products used in sequence: a cleansing gel, an ointment, and a skin conditioner. The formulation is based on a proprietary blend of natural ingredients, including essential oils, herbal extracts, and minerals. It is designed to provide a long-term management solution for psoriasis by removing psoriatic scales, reducing inflammation, and hydrating the skin to prevent recurrences. Clinical studies have demonstrated that Soratinex can be more effective than high-potency corticosteroids like methylprednisolone aceponate for long-term disease control, with a significantly lower risk of side effects. In many European jurisdictions, it is registered and marketed as a Class I medical device.

Brand names
SoratinexDr. Michaels
Other names
Dr. Michaels productsDr. Michaels Psoriasis Program

Beyond the preview

Go deeper on Soratinex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soratinex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call